Sunday, 24 September 2023



LATEST NEWS This Pulwama village wants to ‘get connected’ to world Promoting Dogra heritage biggest tribute to Maharaja Hari Singh ji: Devender Singh Rana Maharaja Hari Singh Ji’s legacy continues to influence region’s historic narrative: Surjeet Singh Slathia Chairman and EMPLOYEES Of Punjab Warehouse contribute Rs 37.95 lakh in CM Relief fund Noble Foundation Organizes Annual 'Swabhiman Awards’ Function Sunam achieves another milestone; All Govt high schools equip with XR Labs Governor Shiv Pratap Shukla flags off cycle campaign Chairman HPSCB contributes Rs 3 lakh from his savings towards the DRF Lt Governor Manoj Sinha, Giriraj Singh visit Simaria, Begusarai; pay tributes to Rashtrakavi Ramdhari Singh Dinkar Free medical camp organized for MC Civic Staff in Doda Fire safety awareness program held at NCC camp Nagrota DG Floriculture inspects swachata works, activities in village Shiendra as Panchayat Prabhari DDC Jammu stresses creation of durable community assets, attention to local needs in village development activities J&K Judicial Academy organises workshop on Gender Sensitization Commissioner Secretary Mandeep Kaur holds awareness camp, inspects SBM assets in Bhaderwah Upcoming Film White Panjab To Highlight Issue Of Punjab’s Youth Falling Prey To Gangs Led By CM Punjab Sets New Record By Providing 7660 Jobs To Youth In Last 25 Days 36524 Government Jobs To Youth Merely In 18 Months, Hands Over Appointment Governor shouldn't talk about debt, we inherited this debt of 3 lakh crores from Akali BJP and Congress governments - Harpal Singh Cheema Narendra Modi lays foundation stone of International Cricket Stadium in Varanasi, Uttar Pradesh Education Minister Harjot Singh Bains flags off two batches of 60 principals for training in Singapore GITAM Bengaluru concludes global conference on green chemistry and sustainable tech


New breakthrough drug may help treat long Covid, cut reinfection risk

Omicron Variant, Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, Health, Research, Study, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Liquid Medical Oxygen, Oximeter
Listen to this article

5 Dariya News

5 Dariya News

5 Dariya News

Sydney , 28 Jun 2023

Australian researchers, including one of Indian-origin, have developed a new drug that could help long Covid symptoms including fatigue, breathlessness and brain fog, affecting between 10 per cent and 20 per cent of the millions infected with Covid-19. 

The drug, NACE2i, is a potential treatment for long Covid that will relieve those debilitating symptoms and revive immune function, said the team from QIMR Berghofer in Brisbane. "We uncovered the pathway that the virus uses to induce the persistent inflammation which causes organ damage found in long Covid. 

This study shows our drug prevents that and even repairs damaged lung tissue in pre-clinical models. It is both a prevention and a treatment," said epigeneticist and co-lead author, Professor Sudha Rao who heads QIMR Berghofer's Gene Regulation & Translational Medicine Group. 

"In the damaged lung, you see it is missing the surface layer of the lung bronchiole area. After treatment with NACE2i, the lung is restored to normal function with a healthy surface layer," added Dr. Wen Juan Tu, QIMR Berghofer Research Officer. 

NACE2i also showed potential to protect against re-infection by any SARS-CoV-2 variant, the team said. In the study, detailed in the journal published in Nature Communications, they described that NACE2i works by reprogramming the hijacked ACE2 receptor which disarms the virus and stops it replicating.

The reprogrammed ACE2 receptor is returned to the cell surface where it acts as a lock that prevents the virus from entering the cell. This process also reverses the inflammation Covid-19 causes in the lungs."The results of the study are really exciting. It shows our drug, NACE2i, stops the virus replicating and protects against re-infection," Rao said. 

"We believe it could be a highly promising adjuvant to boost the effectiveness of existing vaccines providing long-lasting protection against any variant of the virus that tries to enter the cells,” she added.The researchers also developed a biomarker blood test to detect the presence of the protective ACE2 receptor layer around cells. 

They tested this in human blood samples and found it was lacking in patients who had repeated Covid-19 infections. The study found NACE2i restored this biomarker of protection.The next step is to begin clinical trials of NACE2i, the researchers said.


Tags: Omicron Variant , Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , Health , Research , Study , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Liquid Medical Oxygen , Oximeter



related news




Photo Gallery



Video Gallery



5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2023 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD